本頁面由Tiger Trade Technology Pte. Ltd.提供服務

美國血液技術

108.99
+1.391.29%
成交量:24.10萬
成交額:2,639.54萬
市值:49.53億
市盈率:53.17
高:110.45
開:107.81
低:107.60
收:107.60
52周最高:110.45
52周最低:47.32
股本:4,544.60萬
流通股本:4,459.72萬
量比:0.76
換手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):2.05
每股收益(LYR):2.05
淨資產收益率:11.20%
總資產收益率:6.60%
市淨率:5.92
市盈率(LYR):53.17

資料載入中...

2023/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/07

重要事件披露

Form 8-K - Current report
2023/07/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/05/11

重要事件披露

8-K - Current report
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/07

重要事件披露

8-K - Current report
2023/02/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/07

重要事件披露

8-K - Current report
2022/10/19

重要事件披露

8-K - Current report